JP2014527048A5 - - Google Patents

Download PDF

Info

Publication number
JP2014527048A5
JP2014527048A5 JP2014523545A JP2014523545A JP2014527048A5 JP 2014527048 A5 JP2014527048 A5 JP 2014527048A5 JP 2014523545 A JP2014523545 A JP 2014523545A JP 2014523545 A JP2014523545 A JP 2014523545A JP 2014527048 A5 JP2014527048 A5 JP 2014527048A5
Authority
JP
Japan
Prior art keywords
hydroxy
alkyl
cyclo
oxo
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014523545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014527048A (ja
JP6193230B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2012/070411 external-priority patent/WO2013022079A1/en
Publication of JP2014527048A publication Critical patent/JP2014527048A/ja
Publication of JP2014527048A5 publication Critical patent/JP2014527048A5/ja
Application granted granted Critical
Publication of JP6193230B2 publication Critical patent/JP6193230B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014523545A 2011-08-05 2012-08-03 統合失調症の処置方法 Expired - Fee Related JP6193230B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161515418P 2011-08-05 2011-08-05
US61/515,418 2011-08-05
PCT/JP2012/070411 WO2013022079A1 (en) 2011-08-05 2012-08-03 Method for treating schizophrenia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017154092A Division JP2017222708A (ja) 2011-08-05 2017-08-09 統合失調症の処置方法

Publications (3)

Publication Number Publication Date
JP2014527048A JP2014527048A (ja) 2014-10-09
JP2014527048A5 true JP2014527048A5 (enExample) 2015-09-17
JP6193230B2 JP6193230B2 (ja) 2017-09-06

Family

ID=47627335

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014523545A Expired - Fee Related JP6193230B2 (ja) 2011-08-05 2012-08-03 統合失調症の処置方法
JP2017154092A Pending JP2017222708A (ja) 2011-08-05 2017-08-09 統合失調症の処置方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017154092A Pending JP2017222708A (ja) 2011-08-05 2017-08-09 統合失調症の処置方法

Country Status (18)

Country Link
US (2) US8592483B2 (enExample)
EP (1) EP2739278A4 (enExample)
JP (2) JP6193230B2 (enExample)
KR (1) KR20140076551A (enExample)
CN (2) CN107903173A (enExample)
AR (1) AR087468A1 (enExample)
AU (2) AU2012293157A1 (enExample)
BR (1) BR112014002712A8 (enExample)
CA (1) CA2842455A1 (enExample)
HK (1) HK1252353A1 (enExample)
IL (2) IL230552A (enExample)
MX (1) MX359697B (enExample)
NZ (1) NZ620300A (enExample)
RU (1) RU2648474C2 (enExample)
SG (1) SG10201606442QA (enExample)
TW (2) TWI619497B (enExample)
WO (1) WO2013022079A1 (enExample)
ZA (1) ZA201400707B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450128B (zh) * 2013-08-15 2015-04-08 河南中帅医药科技股份有限公司 用于治疗青光眼的前列腺素类似物中间体Corey醛的制备方法
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5428062A (en) 1987-01-28 1995-06-27 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5591887A (en) 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA1324129C (en) 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
CA2030345C (en) 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
DK0857718T3 (da) 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
IL157751A0 (en) * 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
US20040224995A1 (en) * 2003-05-09 2004-11-11 University Of North Texas Health Science Center At Fort Worth Neuroprotective effects of PPARy agonists against cellular oxidative insults
US8202909B2 (en) * 2005-01-27 2012-06-19 Sucampo Ag Method for treating central nervous system disorders
CN103919783A (zh) * 2005-03-04 2014-07-16 苏坎波公司 治疗外周血管病的方法和组合物
US7211703B2 (en) * 2005-04-27 2007-05-01 Calgon Carbon Corporation Method of separating E and Z isomers of an alkene alcohol and derivatives thereof
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
JP5390519B2 (ja) * 2007-07-19 2014-01-15 株式会社アールテック・ウエノ 11−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法
US9259409B2 (en) * 2011-01-24 2016-02-16 Inceptum Research & Therapeutics, Inc. Compositions comprising a prostaglandin for treating neuropsychiatric conditions

Similar Documents

Publication Publication Date Title
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2014505660A5 (enExample)
JP2015518491A5 (enExample)
RU2018114518A (ru) Новые бициклические соединения в качестве двойных ингибиторов аутотаксина (atx)/карбоангидразы (ca)
RU2015151502A (ru) Химические соединения
JP2013510120A5 (enExample)
JP2011502956A5 (enExample)
RU2015154955A (ru) Производные бензотиофенов в качестве ингибиторов рецептора эстрогенов
WO2013121449A8 (en) Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases
MA38138A1 (fr) Dérivés inédits de quinolone
JP2015535831A5 (enExample)
JP2013512277A5 (enExample)
RU2014135436A (ru) Комбинация ингибитора rtk с антиэстрогеном и ее применение для лечения рака
JP2015524450A5 (enExample)
JP2013519653A5 (enExample)
JP2015512943A5 (enExample)
JP2004527567A5 (enExample)
JP2014530838A5 (enExample)
JP2013518036A5 (enExample)
JP2010505865A5 (enExample)
RU2013136895A (ru) Новое бициклическое соединение или его соль
JP2014511825A5 (enExample)
WO2012131656A3 (en) Compounds for use as therapeutic agents affecting p53 expression and/or activity
RU2018113296A (ru) Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения
JP2013513607A5 (enExample)